Actively Recruiting
Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department
Led by University of Monastir · Updated on 2024-02-28
424
Participants Needed
1
Research Sites
265 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department
CONDITIONS
Official Title
Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provided informed consent
- Aged over 18 years
- Have an acute non-traumatic headache
- Being treated in the Emergency Department
- Able to receive intravenous magnesium sulfate and aspirin
You will not qualify if you...
- Regular use of analgesics, anticonvulsants, or antidepressants
- Kidney disorder with low glomerular filtration rate (below 60 ml/min)
- Neuromuscular disorder
- Pregnancy
- Contraindications to treatment
- Allergy to NSAIDs
- Traumatic headache
- Chronic headache occurring at least 15 days per month for at least 3 months
- Hemodynamic instability
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Monasrtir
Monastir, Tunisia, 5060
Actively Recruiting
Research Team
S
Semir Nouira, Professor
CONTACT
K
Khaoula Bel Haj Ali, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here